One of the most recent was a meta-analysis showing that a baseline high CRP level is significantly associated with poor prognosis in early-stage NSCLC or in patients undergoing pneumonectomy for lung cancer [49,50]. The gene discussed is CRP; the disease is non-small cell lung carcinoma.